<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
>

<channel>
	<title>Memory Enhancement Center &#187; Clinical Research Study</title>
	<atom:link href="http://www.memorycenternj.com/index.php/category/clinical-research-study/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.memorycenternj.com</link>
	<description></description>
	<lastBuildDate>Thu, 09 Sep 2010 12:10:49 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<!-- podcast_generator="podPress/8.8" -->
		<copyright>&#xA9;Dr. Joel Ross </copyright>
		<managingEditor>askdrross@memorycenternj.com (Dr. Joel Ross)</managingEditor>
		<webMaster>askdrross@memorycenternj.com(Dr. Joel Ross)</webMaster>
		<category></category>
		<ttl>1440</ttl>
		<itunes:keywords>Alzheimer, Alzheimerrsquo;s, Alzheimerrsquo;s Disease, clinical research, memory loss, Dr. Ross, Dr. Ross NJ, Dr. Ross New Jersey</itunes:keywords>
		<itunes:subtitle></itunes:subtitle>
		<itunes:summary></itunes:summary>
		<itunes:author>Dr. Joel Ross</itunes:author>
		<itunes:category text="Science &amp; Medicine">
  <itunes:category text="Medicine"/>
</itunes:category>
<itunes:category text="Health"/>
		<itunes:owner>
			<itunes:name>Dr. Joel Ross</itunes:name>
			<itunes:email>askdrross@memorycenternj.com</itunes:email>
		</itunes:owner>
		<itunes:block>No</itunes:block>
		<itunes:explicit>no</itunes:explicit>
		<itunes:image href="http://www.memorycenternj.com/wp-content/plugins/podpress/images/powered_by_podpress_large.jpg" />
		<image>
			<url>http://www.memorycenternj.com/wp-content/plugins/podpress/images/powered_by_podpress.jpg</url>
			<title>Memory Enhancement Center</title>
			<link>http://www.memorycenternj.com</link>
			<width>144</width>
			<height>144</height>
		</image>
		<item>
		<title>Will Dimebon be the next FDA approved Drug for AD?</title>
		<link>http://www.memorycenternj.com/index.php/clinical-research-study/will-dimebon-be-the-next-fda-approved-drug-for-ad/</link>
		<comments>http://www.memorycenternj.com/index.php/clinical-research-study/will-dimebon-be-the-next-fda-approved-drug-for-ad/#comments</comments>
		<pubDate>Mon, 11 Jan 2010 17:51:56 +0000</pubDate>
		<dc:creator>Joel Ross</dc:creator>
				<category><![CDATA[Alzheimer’s Disease]]></category>
		<category><![CDATA[Clinical Research Study]]></category>
		<category><![CDATA[Clinical Research Trials]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Dementia]]></category>

		<guid isPermaLink="false">http://www.memorycenternj.com/index.php/uncategorized/will-dimebon-be-the-next-fda-approved-drug-for-ad/</guid>
		<description><![CDATA[I have been very actively researching Dimebon in clinical research studies under strict FDA and industry guidelines, and saw the below article and felt my readers would be most interested in learning more about an &#8220;outsider&#8221; looking in at the potential for this drug if FDA approved for Alzheimer&#8217;s Disease.
For the Treatment of Alzheimer&#8217;s Disease, [...]]]></description>
		<wfw:commentRss>http://www.memorycenternj.com/index.php/clinical-research-study/will-dimebon-be-the-next-fda-approved-drug-for-ad/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Memory Enhancement Center(s) now open in Toms River NJ and Brooklyln NY</title>
		<link>http://www.memorycenternj.com/index.php/uncategorized/memory-enhancement-centers-now-open-in-toms-river-nj-and-brooklyln-ny/</link>
		<comments>http://www.memorycenternj.com/index.php/uncategorized/memory-enhancement-centers-now-open-in-toms-river-nj-and-brooklyln-ny/#comments</comments>
		<pubDate>Thu, 24 Dec 2009 20:08:42 +0000</pubDate>
		<dc:creator>Joel Ross</dc:creator>
				<category><![CDATA[Alzheimer’s Disease]]></category>
		<category><![CDATA[Clinical Research Study]]></category>
		<category><![CDATA[Clinical Research Trials]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Dementia]]></category>
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.memorycenternj.com/index.php/uncategorized/memory-enhancement-centers-now-open-in-toms-river-nj-and-brooklyln-ny/</guid>
		<description><![CDATA[The Memory Enhancement Centers of America are very proud to have added the Toms River NJ site headed by Dr. Sanjiv Sharma, MD (board certified fellowship trained geriatrician) and the Memory Enhancement Center of Brooklyn, headed by Dr. Jeffrey Ben-Zvi, MD (board certified in geriatric medicine).
These two centers of excellence will now provide even more [...]]]></description>
		<wfw:commentRss>http://www.memorycenternj.com/index.php/uncategorized/memory-enhancement-centers-now-open-in-toms-river-nj-and-brooklyln-ny/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Iberica USA opens its new State of Art Phase I/IIA Facility</title>
		<link>http://www.memorycenternj.com/index.php/clinical-research-study/iberica-usa-opens-its-new-state-of-art-phase-iiia-facility/</link>
		<comments>http://www.memorycenternj.com/index.php/clinical-research-study/iberica-usa-opens-its-new-state-of-art-phase-iiia-facility/#comments</comments>
		<pubDate>Fri, 18 Jan 2008 02:39:02 +0000</pubDate>
		<dc:creator>Joel Ross</dc:creator>
				<category><![CDATA[Clinical Research Study]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Alzheimer]]></category>
		<category><![CDATA[Alzheimer’s]]></category>
		<category><![CDATA[Alzheimer’s Disease]]></category>
		<category><![CDATA[clinical research]]></category>
		<category><![CDATA[Dr Ross]]></category>
		<category><![CDATA[Dr. Ross New Jersey]]></category>
		<category><![CDATA[Dr. Ross NJ]]></category>
		<category><![CDATA[memory loss]]></category>

		<guid isPermaLink="false">http://www.memorycenternj.com/index.php/uncategorized/iberica-usa-opens-its-new-state-of-art-phase-iiia-facility/</guid>
		<description><![CDATA[Iberica USA has announced that its new 28 bed inpatient facility is officially open effective January 18, 2008. Iberica&#8217;s Clinical Research Center (ICRC) will bring a new level of high quality phase I/IIA research to the pharmaceutical world.
It &#8220;home like&#8221; environment, 20 single rooms and 4 double bedded rooms, staffed with the most caring and [...]]]></description>
		<wfw:commentRss>http://www.memorycenternj.com/index.php/clinical-research-study/iberica-usa-opens-its-new-state-of-art-phase-iiia-facility/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
			<enclosure url="http://www.memorycenternj.com/wp-content/uploads/DR-JOELROSS.mp3" length="11636402" type="audio/mpeg"/>
<itunes:duration>12:07</itunes:duration>
		<itunes:subtitle>Iberica USA has announced that its new 28 bed inpatient facility is officially open effective January 18, 2008. Iberica's Clinical Research Center (ICRC) will bring ...</itunes:subtitle>
		<itunes:summary>Iberica USA has announced that its new 28 bed inpatient facility is officially open effective January 18, 2008. Iberica's Clinical Research Center (ICRC) will bring a new level of high quality phase I/IIA research to the pharmaceutical world.

It "home like" environment, 20 single rooms and 4 double bedded rooms, staffed with the most caring and qualified personnel will provide outstanding care to healthy volunteers in phase I studies as well as to provide a perfect environment for Japanese Bridging studies.

Dr. Ross's Memory Enhancement Center of America (MECA) will also be conducting clinical trials for Alzheimer's Disease in the safest and most comfortable settings possible within ICRC

The MECA will provide pharmaceutical sponsors with the availability of continuous spinal fluid analysis in Alzheimer's Disease subjects as well as in healthy volunteers to assess the penetration of new compounds through the blood brain barrier, so critically important in the ever growing field of new compounds combating the devastating disease of Alzheimer's.

Dr. Joel Ross discusses the opening of the new Iberica USA facility in Eatontown, New Jersey with WOBM-AM's Bob and Marianne during a radio show interview.</itunes:summary>
		<itunes:keywords>Clinical,Research,Study,,Clinical,Trials</itunes:keywords>
		<itunes:author>Dr. Joel Ross</itunes:author>
		<itunes:explicit>no</itunes:explicit>
		<itunes:block>No</itunes:block>
	</item>
		<item>
		<title>New Approaches to Alzheimer&#8217;s Disease Treatments</title>
		<link>http://www.memorycenternj.com/index.php/clinical-research-study/new-approaches-to-alzheimers-disease-treatments/</link>
		<comments>http://www.memorycenternj.com/index.php/clinical-research-study/new-approaches-to-alzheimers-disease-treatments/#comments</comments>
		<pubDate>Thu, 17 Jan 2008 20:38:46 +0000</pubDate>
		<dc:creator>Joel Ross</dc:creator>
				<category><![CDATA[Alzheimer’s Disease]]></category>
		<category><![CDATA[Clinical Research Study]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Alzheimer's Disease]]></category>
		<category><![CDATA[Confusion]]></category>
		<category><![CDATA[Dementia]]></category>
		<category><![CDATA[Forgetfulness]]></category>
		<category><![CDATA[memory loss]]></category>
		<category><![CDATA[Senility]]></category>

		<guid isPermaLink="false">http://www.memorycenternj.com/index.php/clinical-research-study/new-approaches-to-alzheimers-disease-treatments/</guid>
		<description><![CDATA[   Want to know the newest ways to treat AD? 
Elan progresses two of its Alzheimer&#8217;s compounds with partners
Elan and Transition Therapeutics have started a Phase II trial of the potential Alzheimer&#8217;s disease compound they are jointly developing, ELND005 (formerly AZD-103).
ELND005 is an orally administered product that was shown in animal models to act by preventing and [...]]]></description>
		<wfw:commentRss>http://www.memorycenternj.com/index.php/clinical-research-study/new-approaches-to-alzheimers-disease-treatments/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Americas Seniors: The Overmedicated Society?</title>
		<link>http://www.memorycenternj.com/index.php/clinical-research-study/americas-seniors-the-overmedicated-society/</link>
		<comments>http://www.memorycenternj.com/index.php/clinical-research-study/americas-seniors-the-overmedicated-society/#comments</comments>
		<pubDate>Fri, 11 Jan 2008 22:26:03 +0000</pubDate>
		<dc:creator>Joel Ross</dc:creator>
				<category><![CDATA[Clinical Research Study]]></category>
		<category><![CDATA[Alzheimer]]></category>
		<category><![CDATA[Alzheimer’s]]></category>
		<category><![CDATA[Alzheimer’s Disease]]></category>
		<category><![CDATA[clinical research]]></category>
		<category><![CDATA[memory loss]]></category>

		<guid isPermaLink="false">http://www.memorycenternj.com/index.php/clinical-research-study/americas-seniors-the-overmedicated-society/</guid>
		<description><![CDATA[AMERICAS SENIORS:
THE OVERMEDICATED SOCIETY?
&#160;
The value of a geriatric consultation
&#160;
By Joel S. Ross, MD, FACP, AGSF, CMD
Geriatric Specialist
I saw an elderly patient recently who came for a geriatric evaluation. She had recalled how 15 years earlier I had cared for her husband, and said &#8220;you were so caring for my husband and I hope you can [...]]]></description>
		<wfw:commentRss>http://www.memorycenternj.com/index.php/clinical-research-study/americas-seniors-the-overmedicated-society/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>
